StockNews.com Begins Coverage on Tenax Therapeutics (NASDAQ:TENX)
StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Several other equities analysts also recently weighed in on the company. William Blair reaffirmed an “outperform” rating on shares of Tenax Therapeutics in a […]
StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Several other equities analysts also recently weighed in on the company. William Blair reaffirmed an “outperform” rating on shares of Tenax Therapeutics in a […]
